Medicine and Dentistry
Neuroborreliosis
100%
Inpatient
100%
Patient
78%
Antibiotics
60%
Diagnosis
58%
Retrospective Study
40%
Therapeutic Procedure
40%
Tissues
40%
Pathogen
40%
Pseudomonas aeruginosa
40%
Staphylococcus aureus
20%
Urine
20%
Escherichia coli
20%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
20%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
20%
Coagulase Negative Staphylococcus
20%
Cefalexin
20%
Clindamycin
20%
Benzylpenicillin
20%
Gram-Negative Bacteria
20%
Meticillin
20%
β-Lactam antibiotic
20%
Proteus
20%
Aminopenicillin
20%
Mucosa
20%
Surveillance
20%
Dermatology
20%
Skin
20%
Chemotherapeutic Agent
20%
Drug
20%
Antibiogram
20%
Gram-Positive Bacteria
20%
Antibiotic Therapy
20%
Wound
20%
Cohort Effect
20%
Enterococcus
20%
Blood
20%
Biological Marker
16%
Clinically Isolated Syndrome
8%
Paraneoplastic Syndrome
8%
Analysis
8%
Antibody
8%
CXCL13 Chemokine
8%
Tuberculosis
8%
Sensitivity and Specificity
8%
Neurology
8%
Syphilis
8%
Borrelia burgdorferi
8%
Pharmacology, Toxicology and Pharmaceutical Science
Defined Daily Dose
60%
Soft Tissue Infection
40%
Infectious Agent
40%
Pseudomonas aeruginosa
40%
Cefalexin
20%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
20%
Drug
20%
Coagulase Negative Staphylococcus
20%
Gram Positive Bacterium
20%
Gram Negative Bacterium
20%
Escherichia coli
20%
Clindamycin
20%
Proteus
20%
Enterococcus
20%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
20%
Penicillin G
20%
Beta Lactam Antibiotic
20%
Aminopenicillin
20%
Wound
20%
Epidemiology
20%
Meticillin
20%
Antibiotic Agent
20%
Immunology and Microbiology
Sample
58%
Bacterium
41%
Surface Property
37%
Staphylococcus aureus
25%
Staphylococcus Phage
25%
Coliphage
20%
Escherichia coli
20%
Prophage
20%
Species
16%
Urine
16%
Identity
16%
Staphylococcus Aureus
12%
Klebsiella
12%
Microorganism
12%
Prevalence
8%
Paraneoplastic Syndrome
8%
Borrelia burgdorferi
8%
Genus
8%
Host
8%
Human
8%
CXCL13 Chemokine
8%
Bacterial Genome
8%
Attention
8%
Phylogeny
8%
Parasite
8%
Electric Potential
8%
Monospecific Antibody
8%